Production of chimeric antibodies by homologous recombination

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5202238
SERIAL NO

07468035

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A process for producing chimeric antibodies using novel recombinant DNA vectors and homologous recombination in vivo is described. The recombinant DNA constructs of the invention can be used to transfect antibody producing cells so that targeted homologous recombination occurs in the transfected cells leading to gene modification and the production of chimeric antibody molecules by the transfected cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ONCOGEN 3005 FIRST AVENUEA LIMITED PARTNERSHIP OF WA SEATTLE WA 98121

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fell, Jr H Perry Redmond, WA 2 236
Folger-Bruce, Kim R Seattle, WA 2 236

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation